ViiV Culture=Backstabbing

I just completed my first DTG/3TC spreadsheet. Looking good, I tell you! I’m going to spreadsheet this baby to the top, so I’m not one getting let go during the downsizing.

 

You do realize that consumer isn't located in NC or PA right? Consumer is in NJ and has always had a separate location than the Pharma and Vaccine units.

 

Good luck to all of my peers at ViiV looking to get out prior to the layoffs. I just found a new job. It is much easier to do now than wait until the announcement, as we still don’t know how massive the layoffs will be.

 

Ha! Possibly written by a manager looking to “ help” people leave as soon as possible without any benefits

 

i am having difficulty finding other companies take me seriously because of our lack of sales numbers/ridiculous set up versus almost all other companies. ViiV is going to be hard to get away from before layoffs!

 

I have heard that exact same thing from many others. Have not yet started looking. How much time do you think before the house of cards collapses? I dont think we have more than a year.

 

I’m not original poster, but I think GSK/ViiV is hoping people leave to avoid severance. I’m thinking we get through launching DTG/3TC, and once those disappointing numbers start rolling in, heads will roll. Late summer at the latest.

 

Please get me out of the ViiV/GSK clown show. This isn’t sales, it’s make believe....And I ain’t Mister Rogers! I have too many neighbors in this POD!

 

Ha - yes. 1 from each POD must go, and DTG/3TC is going to rock!

 

What are you smoking....DTG/3TC is going to suck worse than Juluca for sure, and that’s hard to imagine.

 

I’m guessing they are holding off on laying off us at ViiV until July or August.

 

Or Fall - big layoffs

 

What about respiratory?

 

Both HIV and Respiratory on chopping block this year...

 

I’m our of here - this company sucks!

 

I’ve heard severance for us let go in HIV will be delayed like everyone else. GSK sucks!

 

Just heard 40% reduction in HIV sales (ViiV) was approved.....

 

DTG/3TC will do even worse than Juluca. Why?

Because we rushed Juluca to market during the Christmas holiday season in 2017 because we were desperate to beat Biktarvy to market,..., and launched miserably anyway.

Now Biktarvy is well established as a market leader and we are launching another 2 drug dog.

Just being real. I am looking and hoping to get a new job before dealing with another bad launch and layoffs.

 

I am astounded by our doubling down on the 2 Drug strategy. We are being told to remain enthusiastic about D3 while there is literally no interest in 2 drug HIV regimens. Every single HIV provider I have spoken to almost laughs at my face when talking about 2DR. If D3 sucks worse than Juluca this may well be the end of the company in its present form. Leadership is either delusional when banking on D3 or they give the impression so that there isn't widespread chaos as they start dismantling the HIV space. I don't see much upside to the whole 2D strategy